More research is needed to better understand the overall risk , if any, to humans You have multiple endocrine neoplasia syndrome type 2 (MEN2), a rare inherited disorder that causes tumors Youve had pancreatitis in the last six months You are allergic to semaglutide or any of its ingredients You are planning to have surgery or other procedures that use anesthesia Stop taking semaglutide and seek immediate medical care if you develop symptoms such as: Trouble breathing or swallowing Swelling of the tongue or lips Severe itching or hives Rapid heartbeat, dizziness, or fainting Thoughts of harming yourself Other important considerations Before starting semaglutide, tell your healthcare provider if you have or have had: Kidney or pancreas problems Type 2 diabetes with a history of diabetic retinopathy Depression, suicidal thoughts, or other mental health concerns You should also let your provider know about any medications you take (including prescriptions, over-the-counter drugs, vitamins, or supplements)
The standard titration schedule moves from 0.25 mg to 0.5 mg, then 1 mg, and finally 2.4 mg as the maximum therapeutic dose for weight loss
In Study 5, the proportions of patients who discontinued study drug were 5.8% and 11.6% for WEGOVY and placebo, respectively
Of first major adverse CV events reported, 11.2% occurred during the first 20 weeks, favoring the semaglutide group (HR = 0.58
Lopaschuk GD, Verma S (2020) Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review
CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
